Fundraising Fox

Reflux

Bremerton, US · Founded 2024 · Washington corporation

Healthtech

Founders & leadership

TB
Thomas BallNamed on SEC filing

Board

BS
Bert SutterBoard director
SO
Shaun O'NeilBoard director
DC
Daniel CapuanoBoard director
RM
Richard MocklerBoard director

Reported raises · per SEC filings

Form D private placements

$525K disclosed across 1 round · 2026

▶$525KraisedMay 2026 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bert SutterDirector
  • Thomas BallExecutive Officer, Director, Promoter
  • Shaun O'NeilDirector
  • Daniel CapuanoDirector
  • Richard MocklerDirector
Offering amount
$1M
Amount sold
$525K
First sale
Apr 2026
Incorporated
Corporation, Washington, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

N-Zyme Raises $4.6 Million to Fund Mid-Stage Reflux Trials - MyChesComychesco.com · Aug 2026N-Zyme Biomedical Raises $4.6 Million Series A To Advance Reflux Disease Treatmentspulse2.com · Jul 2026

Frequently asked questions

How much funding has Reflux raised?
Reflux has disclosed $525K raised across 1 round.
Where is Reflux headquartered?
Reflux is headquartered in Bremerton, US.